Matthews Mmopi

African nations are on the precipice of momentous changes in the healthcare landscape. Challenges in infectious disease still ravage major segments of the continent while chronic illnesses are emerging as the leading causes of morbidity and mortality. The push for changes, however, has often led to the adoption of partial solutions while the COVID-19 pandemic revealed that the most difficult problems remain unresolved. In this session, we are convening an elite group of professionals, ranging from drug manufacturers, regulators, entrepreneurs, and astute investors to discuss the critical issue of pharmaceutical production on the continent. This session is meticulously designed for decision-makers and innovators seeking to capture tremendous opportunity and make a tangible impact in the healthcare sector. 

‍